Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
30,800
+28,650
+1,333% +$1.91M 0.83% 37
2026
Q1
$135K Buy
2,150
+150
+8% +$10.4K 0.07% 128
2025
Q4
$133K Buy
2,000
+500
+33% +$32.3K 0.06% 127
2025
Q3
$101K Hold
1,500
0.05% 130
2025
Q2
$131K Buy
1,500
+400
+36% +$31.4K 0.07% 123
2025
Q1
$75.1K Hold
1,100
0.05% 135
2024
Q4
$85.5K Buy
+1,100
New +$81.4K 0.05% 135

Other funds holding DXCM

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s DXCM Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) increased its DexCom (DXCM) stake by 1,333% in Q2 2026, buying an estimated $1.91M and bringing the position to 30,800 shares worth $2.07M. The position accounts for 0.83% of the portfolio, ranked #37.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. 679 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 30,800 shares of DexCom worth $2.07M as of Q2 2026.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) bought 28,650 DexCom shares in Q2 2026, an estimated $1.91M.
  • DexCom made up 0.83% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #37 holding.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • 679 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.